Pure Global

Comparison of %5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome - Trial NCT06360510

Access comprehensive clinical trial information for NCT06360510 through Pure Global AI's free database. This phase not specified trial is sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital and is currently Recruitment Completed. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06360510
Recruitment Completed
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT06360510
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Comparison of %5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome
Comparison of the Effectiveness of Ultrasound-guided 5% Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome.

Study Focus

Carpal Tunnel Syndrome

%5 dextrose injection

Observational

procedure

Sponsor & Location

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Ankara, Turkey

Timeline & Enrollment

N/A

May 05, 2023

May 05, 2024

30 participants

Primary Outcome

vas

Summary

The aim of the study is to compare the effectiveness of ultrasound-guided betamethasone and
 5% dextrose injection, which is routinely applied in clinical practice, in patients with mild
 and moderate carpal tunnel syndrome (CTS).

ICD-10 Classifications

Carpal tunnel syndrome
Tarsal tunnel syndrome
Arthrosis of first carpometacarpal joint, unspecified
Arthrosis of first carpometacarpal joint
Other specified disorders of synovium and tendon

Data Source

ClinicalTrials.gov

NCT06360510

Non-Device Trial